Skip to main content
SpringerLink
Log in

Serum uromodulin levels, MR imaging findings, and their relationship with eGFR-based CKD staging in ADPKD patients

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease that may progress to end-stage renal disease, characterized by increased kidney volume due to cystic formations. In this study, we aimed to investigate the relationship between serum uromodulin levels, total kidney volume and estimated glomerular filtration rate (eGFR) in patients with ADPKD.

Methods

This study included a total of 54 ADPKD patients and 18 healthy volunteers (control group). Total kidney volumes were calculated through magnetic resonance images using ellipsoid method. Serum uromodulin measurements were measured using an ELISA method.

Results

Serum uromodulin levels were lower in patients compared with the control group (2.47 ± 0.16 vs 2.6 ± 0.28, p = 0.021). There was no significant difference in uromodulin values among the patients in chronic kidney disease (CKD) stages 1–2, 3 and 4–5. TKV measurements of CKD stage 4–5 patients were significantly higher than the stage 1–2 patients (p = 0.015). A negative correlation was observed between TKV and eGFR (r = − 0.433, p = 0.001). A positive correlation was observed between uromodulin and eGFR (r = 0.274, p = 0.02). When the serum levels of uromodulin and the level of eGFR were evaluated using simple linear regression analysis, R2 value was found to be 0.075, suggesting that 7.5% change in serum uromodulin values corresponds with the change in eGFR value.

Conclusion

These findings are consistent with previous studies that reported that serum uromodulin may be a good biomarker for demonstrating renal function in the early stages of CKD, before eGFR levels deteriorate. Serum uromodulin level may be useful in demonstrating renal functions in the follow-up of individuals with ADPKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Akoh JA (2015) Current management of autosomal dominant polycystic kidney disease. World J Nephrol 4(4):468–479

    Article  Google Scholar 

  2. Sommerer C, Zeier M (2016) Clinical manifestation and management of ADPKD in Western countries. Kidney Dis (Basel) 2(3):120–127

    Article  Google Scholar 

  3. Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321–337

    Article  CAS  Google Scholar 

  4. Spithoven EM, van Gastel MD, Messchendorp AL et al (2015) Estimation of total kidney volume in autosomal dominant polycystic kidney disease. Am J Kidney Dis 66(5):792–801

    Article  Google Scholar 

  5. Tangri N,Hougen I, Alam A, et al. (2017) Total kidney volume as a biomarker of disease progression in autosomal dominant polycystic kidney disease. Can J Kidney Health Dis. https://doi.org/10.1177/2054358117693355

  6. Chapman AB, Guay-Woodford LM, Grantham JJ et al (2003) Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort1. Kidney Int 64(3):1035–1045

    Article  Google Scholar 

  7. Chapman AB, Bost JE, Torres VE et al (2012) Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am SocNephrol. 7(3):479–486

    Article  CAS  Google Scholar 

  8. Kline TL, Korfiatis P, Edwards ME et al (2016) Automatic total kidney volume measurement on followup magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression. Nephrol Dial Transpl 31(2):241–248

    Google Scholar 

  9. Wu TH, Li KJ, Yu CL, et al. (2018) Tamm–Horsfall protein is a potent immunomodulatory molecule and a disease biomarker in the urinary system. Molecules. 23(1):E200. https://doi.org/10.3390/molecules23010200

  10. Dawnay A, Cattell W (1981) Serum Tamm-Horsfall glycoprotein levels in health and in renal disease. ClinNephrol 15(1):5–8

    CAS  Google Scholar 

  11. Hanudel MR, Salusky IB, Pereira RC et al (2019) Erythropoietin and fibroblast growth factor 23 in autosomal dominant polycystic kidney disease patients. Kidney Int Rep 4(12):1742–1748

    Article  Google Scholar 

  12. Leiherer A, Muendlein A, Saely CH et al (2018) The value of uromodulin as a new serum marker to predict decline in renal function. J Hypertens 36(1):110–118

    Article  CAS  Google Scholar 

  13. Steubl D, Block M, Herbst V et al (2016) Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney disease patients. Medicine (Baltimore) 95(10):e3011. https://doi.org/10.1097/md.0000000000003011

    Article  CAS  Google Scholar 

  14. Risch L, Lhotta K, Meier D et al (2014) The serum uromodulin level is associated with kidney function. ClinChem Lab Med 52(12):1755–1761

    CAS  Google Scholar 

  15. Thornley C, Dawnay A, Cattell W (1985) Human Tamm-Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay. Clin Sci (Lond) 68(5):529–535

    Article  CAS  Google Scholar 

  16. Irazabal MV, Rangel LJ, Bergstralh EJ et al (2015) Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol 26(1):160–172

    Article  CAS  Google Scholar 

  17. Chapman AB, Johnson AM, Gabow PA et al (1994) Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5(6):1349–1354

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine, Akdeniz University Hospital, Dumlupinar Bulvari, Konyaaltı, 07070, Antalya, Turkey

    Hale Nur Cansever, Funda Sari, Can Cevikol, Ramazan Cetinkaya, Gultekin Süleymanlar & Fevzi Ersoy

Authors
  1. Hale Nur Cansever
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Funda Sari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Can Cevikol
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ramazan Cetinkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gultekin Süleymanlar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fevzi Ersoy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Funda Sari.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cansever, H.N., Sari, F., Cevikol, C. et al. Serum uromodulin levels, MR imaging findings, and their relationship with eGFR-based CKD staging in ADPKD patients. Int Urol Nephrol 53, 1383–1389 (2021). https://doi.org/10.1007/s11255-020-02730-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-020-02730-5

Keywords

Search

Navigation